Home/Filings/4/0001764013-22-000126
4//SEC Filing

Pande Atul 4

Accession 0001764013-22-000126

CIK 0001764013other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:27 PM ET

Size

6.1 KB

Accession

0001764013-22-000126

Insider Transaction Report

Form 4
Period: 2022-09-30
Pande Atul
Director
Transactions
  • Purchase

    Common Stock

    2022-09-30$5.60/sh+15,000$84,00020,000 total(indirect: By Trust)
Holdings
  • Common Stock

    82,985
Footnotes (3)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.59 - $5.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
  • [F2]These shares are owned by a trust (the "Trust"). Certain members of the Reporting Person's immediate family are beneficiaries of the Trust.
  • [F3]Represents the number of shares underlying restricted stock units awards ("RSUs").

Issuer

Immunovant, Inc.

CIK 0001764013

Entity typeother

Related Parties

1
  • filerCIK 0001643071

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:27 PM ET
Size
6.1 KB